Ex-NIH boss is new R&D head at Sanofi-Aventis
This article was originally published in Scrip
Dr Elias Zerhouni has been appointed president of global R&D at Sanofi-Aventis, which covers medicines and vaccines, effective 1 January. Dr Marc Cluzel is resigning as executive vice president of R&D at the company but will continue in an advisory capacity for the time-being. Dr Zerhouni has been scientific advisor to CEO Christopher Viehbacher since February 2009. In October 2008 he stepped down as the director of the US NIH after more than six years in the position. He is currently professor of radiology and biomedical engineering at the John Hopkins University and Hospital (US).